Neoleukin Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 823 | 0.00876% |
Individual Insiders | 1,547,281 | 16.5% |
Institutions | 1,852,589 | 19.7% |
Hedge Funds | 2,396,507 | 25.5% |
General Public | 3,600,701 | 38.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,814,064 | US$6.3m | 48.5% | 0.03% | |||
582,443 | US$2.0m | 0% | 0.07% | |||
555,838 | US$1.9m | 0% | no data | |||
511,667 | US$1.8m | 0% | no data | |||
464,737 | US$1.6m | -3.13% | no data | |||
310,000 | US$1.1m | 0% | no data | |||
299,999 | US$1.0m | 0% | 0.13% | |||
231,294 | US$807.2k | -0.1% | no data | |||
201,539 | US$703.4k | -0.31% | no data | |||
163,447 | US$570.4k | -12.8% | no data | |||
107,671 | US$375.8k | -34.5% | no data | |||
98,664 | US$344.3k | 1,980% | 0.33% | |||
96,613 | US$337.2k | -0.18% | no data | |||
62,885 | US$219.5k | 4.44% | no data | |||
37,756 | US$131.8k | -69% | no data | |||
34,206 | US$119.4k | -19% | no data | |||
33,880 | US$118.2k | -8.18% | no data | |||
27,335 | US$95.4k | 0% | no data | |||
24,916 | US$87.0k | 0% | 0.04% | |||
24,510 | US$85.5k | 0% | no data | |||
24,037 | US$83.9k | 0.18% | 0.01% | |||
21,961 | US$76.6k | 129% | no data | |||
13,869 | US$48.4k | 56.4% | no data | |||
13,727 | US$47.9k | -1.3% | no data | |||
13,154 | US$45.9k | 0% | no data |